Gassenmaier Christoph, Schittenhelm Jens, Selo Nadja, Schnauder Günter
Medizinische Klinik IV, Universitätsklinikum Tübingen.
Institut für Pathologie und Neuropathologie, Universitätsklinikum Tübingen.
Dtsch Med Wochenschr. 2014 Dec;139(50):2602. doi: 10.1055/s-0034-1387424. Epub 2014 Dec 4.
We report on a 44-year-old woman who was treated for borderline personality disorder in the Department of Psychiatry. In addition, symptoms of hyperthyroidism (anxiety, weight loss, hyperdefecation) were noticeable. Thyroid stimulating hormone (TSH) was marginally elevated, free triiodothyronine (T3) and free thyroxine (T4) were clearly elevated. Hence, the patient was transferred to the Department of Endocrinology.
Thyroid ultrasound revealed a diffuse goiter with a total volume of 24,8 ml. Antibody screening did not show elevated titers. The thyrotropin releasing hormone (TRH) test depicted a blunted TSH response. Serum levels of free glycoprotein hormone alpha-subunit, prolactin and insulin-like growth factor 1 were increased.
DIAGNOSIS, TREATMENT AND COURSE: In cranial magnetic resonance imaging (MRI), a hypointense lesion on the left side of the anterior pituitary gland was detected indicating a thyrotropin-secreting microadenoma with concomitant secretion of prolactin and possible secretion of human growth hormone (HGH). A thyreostatic therapy was initiated aiming at euthyreosis. For symptom control, betablockers were administered. Subsequently, the patient underwent an uncomplicated transsphenoidal resection. Histological examination confirmed the diagnosis of a pituitary adenoma with expression of TSH, prolactin and HGH. As expected, thyroid hormones declined afterwards.
TSHoma is rare. Diagnosis is confirmed by endocrinological testing and cranial imaging. Therapeutic options comprise transsphenoidal adenomectomy, drug therapy (somatostatin analogues, dopaminergic agonists) and irradiation. Resistance to thyroid hormones should be included in the differential diagnosis.
我们报告一名44岁女性,她在精神科接受边缘性人格障碍治疗。此外,甲状腺功能亢进症状(焦虑、体重减轻、排便增多)明显。促甲状腺激素(TSH)略有升高,游离三碘甲状腺原氨酸(T3)和游离甲状腺素(T4)明显升高。因此,患者被转至内分泌科。
甲状腺超声显示弥漫性甲状腺肿,总体积为24.8毫升。抗体筛查未显示滴度升高。促甲状腺激素释放激素(TRH)试验显示TSH反应减弱。游离糖蛋白激素α亚基、催乳素和胰岛素样生长因子1的血清水平升高。
诊断、治疗及病程:在头颅磁共振成像(MRI)中,发现垂体前叶左侧有一个低信号病变,提示分泌促甲状腺激素的微腺瘤,伴有催乳素分泌,可能还分泌人生长激素(HGH)。开始进行甲状腺功能正常化的抗甲状腺治疗。为控制症状,给予β受体阻滞剂。随后,患者接受了无并发症的经蝶窦切除术。组织学检查证实为垂体腺瘤,表达TSH、催乳素和HGH。正如预期的那样,术后甲状腺激素水平下降。
促甲状腺激素瘤罕见。通过内分泌检查和头颅成像确诊。治疗选择包括经蝶窦腺瘤切除术、药物治疗(生长抑素类似物、多巴胺能激动剂)和放疗。鉴别诊断应考虑甲状腺激素抵抗。